NYSE: PG
Procter & Gamble Co Stock

$173.82-2.21 (-1.26%)
Updated Dec 6, 2024
PG Price
$173.82
Fair Value Price
N/A
Market Cap
$409.35B
52 Week Low
$142.50
52 Week High
$180.43
P/E
29.26x
P/B
7.9x
P/S
4.86x
PEG
2.86x
Dividend Yield
2.28%
Revenue
$83.91B
Earnings
$14.32B
Gross Margin
51.4%
Operating Margin
22.59%
Profit Margin
17.1%
Debt to Equity
1.43
Operating Cash Flow
$19B
Beta
0.55
Next Earnings
Jan 21, 2025
Ex-Dividend
N/A
Next Dividend
N/A

PG Overview

The Procter & Gamble Company offersbranded consumer packaged goods in the U.S. and internationally. It operates five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. It well-known brands include Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Metamucil, Neurobion, Pepto-Bismol, Vicks, Ariel, Downy, Gain, and Tide. Procter & Gamble was founded in 1837 and is headquartered in Cincinnati, OH.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine PG's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
D
Growth
C
Momentum
C
Sentiment
A
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Household & Personal Product

Industry Rating
B
PG
Ranked
#14 of 25

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$166.97A
$11.01B
$8.22B
View Top Household & Personal Product Stocks

Be the first to know about important PG news, forecast changes, insider trades & much more!

PG News

Overview

Due Diligence Score

Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PG ($173.82) is trading above its intrinsic value of $55.01, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PG is good value based on its earnings relative to its share price (29.26x), compared to the US market average (29.86x)
P/E vs Market Valuation
PG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PG due diligence checks available for Premium users.

Valuation

PG price to earnings (PE)

For valuing profitable companies with steady earnings

Company
29.26x
Industry
32.87x
Market
29.86x
PG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

PG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
7.9x
Industry
7.51x
PG is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PG price to earnings growth (PEG)

For valuing profitable companies with growth potential

PG is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

PG's financial health

Profit margin

Revenue
$21.7B
Net Income
$4.0B
Profit Margin
18.2%
PG's Earnings (EBIT) of $18.95B... subscribe to Premium to read more.
Interest Coverage Financials
PG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$126.5B
Liabilities
$74.3B
Debt to equity
1.43
PG's short-term liabilities ($36.42B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PG's long-term liabilities ($37.92B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.3B
Investing
-$1.1B
Financing
-$634.0M
PG's operating cash flow ($19.24B)... subscribe to Premium to read more.
Debt Coverage Financials

PG vs Household & Personal Product Stocks

TickerZen RatingMarket Cap1d %P/EP/B
PGC$409.35B-1.26%29.26x7.90x
UL$147.33B-0.86%20.50x6.67x
CLC$76.99B-0.91%27.00x176.98x
KMBC$44.93B-2.48%17.41x34.97x
KVUEC$43.79B-1.25%41.53x4.11x

Procter & Gamble Co Stock FAQ

What is Procter & Gamble Co's quote symbol?

(NYSE: PG) Procter & Gamble Co trades on the NYSE under the ticker symbol PG. Procter & Gamble Co stock quotes can also be displayed as NYSE: PG.

If you're new to stock investing, here's how to buy Procter & Gamble Co stock.

What is the 52 week high and low for Procter & Gamble Co (NYSE: PG)?

(NYSE: PG) Procter & Gamble Co's 52-week high was $180.43, and its 52-week low was $142.50. It is currently -3.66% from its 52-week high and 21.98% from its 52-week low.

How much is Procter & Gamble Co stock worth today?

(NYSE: PG) Procter & Gamble Co currently has 2,355,041,729 outstanding shares. With Procter & Gamble Co stock trading at $173.82 per share, the total value of Procter & Gamble Co stock (market capitalization) is $409.35B.

Procter & Gamble Co stock was originally listed at a price of $39.91 in Dec 31, 1997. If you had invested in Procter & Gamble Co stock at $39.91, your return over the last 26 years would have been 335.58%, for an annualized return of 5.82% (not including any dividends or dividend reinvestments).

How much is Procter & Gamble Co's stock price per share?

(NYSE: PG) Procter & Gamble Co stock price per share is $173.82 today (as of Dec 6, 2024).

What is Procter & Gamble Co's Market Cap?

(NYSE: PG) Procter & Gamble Co's market cap is $409.35B, as of Dec 7, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Procter & Gamble Co's market cap is calculated by multiplying PG's current stock price of $173.82 by PG's total outstanding shares of 2,355,041,729.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.